[Pneumatic external counterpulsation--a therapy option in angina pectoris]

Area of Science:

• Cardiovascular Physiology
• Non-invasive Hemodynamics
• Vascular Biology

Context:

• Angina pectoris remains a significant challenge, particularly in patients refractory to conventional medical and interventional therapies.
• Pneumatic external counterpulsation (PECP) offers a non-invasive method to augment diastolic pressure and enhance coronary perfusion.
• Understanding the mechanisms and clinical efficacy of PECP is crucial for optimizing treatment strategies.

Purpose:

• To evaluate the clinical effectiveness of Pneumatic External Counterpulsation (PECP) in reducing angina pectoris.
• To investigate the physiological mechanisms underlying the benefits of PECP, including collateral circulation.
• To assess the safety and feasibility of PECP as an adjunct therapy for refractory angina.

Summary:

• Pneumatic external counterpulsation (PECP) involves applying ECG-triggered diastolic pressure to the lower limbs via cuffs.
• Repeated PECP sessions (1-2 hours daily for 4-7 weeks) demonstrated significant reduction in angina pectoris across multiple patient cohorts.
• Clinical improvements were corroborated by enhanced exercise tolerance and myocardial perfusion, as evidenced by exercise testing and thallium scanning.

Impact:

• PECP presents a virtually risk-free treatment alternative for patients with angina unresponsive to standard treatments.
• The therapy may promote beneficial vascular remodeling, including collateral vessel opening and growth, contributing to long-term clinical benefits.
• This approach holds promise for improving quality of life and reducing symptom burden in challenging cardiovascular patient populations.